GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
+7.58%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.62B
AUM Growth
–
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
637
New
637
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NVIDIA
NVDA
|
$390M |
| 2 |
Apple
AAPL
|
$374M |
| 3 |
Microsoft
MSFT
|
$322M |
| 4 |
Amazon
AMZN
|
$234M |
| 5 |
Meta Platforms (Facebook)
META
|
$194M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 45.53% |
| 2 | Consumer Discretionary | 17.29% |
| 3 | Communication Services | 14.35% |
| 4 | Healthcare | 6.6% |
| 5 | Consumer Staples | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEM
326
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $108K | ﹤0.01% |
+3,200
| New | +$108K |
|
327
Ryman Hospitality Properties
RHP
$6.35B
| $108K | ﹤0.01% |
+1,034
| New | +$108K |
|
328
Nuvalent
NUVL
$5.83B
| $108K | ﹤0.01% |
+1,378
| New | +$108K |
|
329
Americold
COLD
$3.98B
| $105K | ﹤0.01% |
+4,905
| New | +$105K |
|
330
Terreno Realty
TRNO
$6.1B
| $104K | ﹤0.01% |
+1,761
| New | +$104K |
|
331
Kite Realty
KRG
$5.11B
| $101K | ﹤0.01% |
+3,992
| New | +$101K |
|
332
Essential Properties Realty Trust
EPRT
$6.1B
| $99.7K | ﹤0.01% |
+3,186
| New | +$99.7K |
|
333
Crinetics Pharmaceuticals
CRNX
$3.35B
| $99.6K | ﹤0.01% |
+1,947
| New | +$99.6K |
|
334
Alkermes
ALKS
$4.94B
| $97.7K | ﹤0.01% |
+3,397
| New | +$97.7K |
|
335
Krystal Biotech
KRYS
$4.35B
| $94.6K | ﹤0.01% |
+604
| New | +$94.6K |
|
336
Macerich
MAC
$4.74B
| $90K | ﹤0.01% |
+4,516
| New | +$90K |
|
337
Arcellx
ACLX
$4.03B
| $87K | ﹤0.01% |
+1,135
| New | +$87K |
|
338
Axsome Therapeutics
AXSM
$6.25B
| $86.1K | ﹤0.01% |
+1,018
| New | +$86.1K |
|
339
ADMA Biologics
ADMA
$4.03B
| $85.1K | ﹤0.01% |
+4,964
| New | +$85.1K |
|
340
Scholar Rock
SRRK
$3.02B
| $85K | ﹤0.01% |
+1,966
| New | +$85K |
|
341
Cousins Properties
CUZ
$4.95B
| $84.7K | ﹤0.01% |
+2,765
| New | +$84.7K |
|
342
Phillips Edison & Co
PECO
$4.54B
| $83.4K | ﹤0.01% |
+2,226
| New | +$83.4K |
|
343
Apellis Pharmaceuticals
APLS
$3.55B
| $83.3K | ﹤0.01% |
+2,612
| New | +$83.3K |
|
344
Independence Realty Trust
IRT
$4.22B
| $83.3K | ﹤0.01% |
+4,198
| New | +$83.3K |
|
345
Philip Morris
PM
$251B
| $82.9K | ﹤0.01% |
+689
| New | +$82.9K |
|
346
Kilroy Realty
KRC
$5.05B
| $82K | ﹤0.01% |
+2,026
| New | +$82K |
|
347
Ultragenyx Pharmaceutical
RARE
$3.07B
| $81.6K | ﹤0.01% |
+1,939
| New | +$81.6K |
|
348
SL Green Realty
SLG
$4.4B
| $80K | ﹤0.01% |
+1,178
| New | +$80K |
|
349
Guardant Health
GH
$7.5B
| $79.2K | ﹤0.01% |
+2,594
| New | +$79.2K |
|
350
American Healthcare REIT
AHR
$7.2B
| $78.4K | ﹤0.01% |
+2,758
| New | +$78.4K |
|